PSYCH up2date, Table of Contents Psychiatrie und Psychotherapie up2date 2009; 3(04): 241-255DOI: 10.1055/s-0029-1220347 Essstörungen, somatische Belastungsstörungen, Schlafstörungen und sexuelle Funktionsstörungen Psychopharmaka und sexuelle Störungen Daniel Schöttle , Martin Lambert , Christian G. Huber , Peer BrikenRecommend Article Abstract Buy Article All articles of this category Full Text References Weiterführende Literatur Neurotransmitter, Rezeptoren und Hormone Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence.. Hum Psychopharmacol Clin Exp 2008; 23: 201-209 Balon R. Introduction: new developments in the area of sexual dysfunction(s).. Adv Psychosom Med 2008; 29: 1-6 Meston CM, Frohlich P. The Neurobiology of Sexual Function.. Arch Gen Psychiatry 2000; 57: 1012-1030 Holsboer DF, Gründer G, Benkert O. et al. Handbuch der Psychopharmakotherapie. 1. Aufl.. Berlin: Springer 2007 Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 3rd ed.. Cambridge: University Press 2008 Medikation und sexuelle Funktionsstörung Byerly M, Suppes T, Tran QV. et al. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.. J Clin Psychopharmacol 2007; 27 (6): 639-661 Carey JC. Pharmacological effects on sexual function.. Obstet Gynecol Clin North Am 2006; 33 (4): 599-620 Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.. Int Clin Psychopharmacol 2003; 18 (3): 151-156 Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE. et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.. J Clin Psychiatry 2006; 67 (5): 736-746 Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F. et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.. J Clin Psychiatry 2005; 66 (6): 686-692 Haberfellner EM. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials.. Pharmacopsychiatry 2007; 40 (5): 173-182 Holt RI. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.. J Psychopharmacol 2008; 22 (Suppl. 2): 28-37 Kammerahl D, Schottle D, Huber CG. Sexualität und Schizophrenie. Eine Übersicht.. Z Sexualforsch 2008; 21 (2): 165-180 Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.. J Clin Psychopharmacol 2008; 28 (3): 329-333 Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.. J Clin Psychiatry 2001; 62 (Suppl. 3): 10-21 Montejo A, Prieto N, Terleira A, Matias J, Alonso S, Paniagua G. et al. Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.. J Psychopharmacol 21.11.2008 Peveler RC, Branford D, Citrome L. et al. Antipsychotics and hyperprolactinaemia: clinical recommendations.. J Psychopharmacol 2008; 22 (Suppl. 2): 98-103 Segraves RT. Sexual dysfunction associated with antidepressant therapy.. Urol Clin North Am 2007; 34 (4): 575-579 Walters J, Jones I. Clinical questions and uncertainty – prolactin measurement in patients with schizophrenia and bipolar disorder.. J Psychopharmacol 2008; 22 (Suppl. 2): 82-89 Westheide J, Cohen S, Bender S. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication.. Pharmacopsychiatry 2007; 40 (4): 140-145 Behandlung der medikamentenassoziierten sexuellen Funktionsstörung Hartmann U, Rüffer-Hesse C. Sexuality and pharmacotherapy.. Medication-induced disorders of sexual response and pharmacotherapeutic options for the treatment of sexual dysfunctions, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50 (1): 19-32 Hauch M. Paartherapie bei sexuellen Störungen.. Stuttgart: Georg Thieme Verlag 2005 Schöttle D, Kammerahl D, Huber J. et al. Sexuelle Störungen bei Menschen mit einer schizophrenen Erkrankung.. Psychiat Prax 2009; 36 (4): 160-168 Sigusch V. Sexuelle Störungen und ihre Behandlung.. Stuttgart: Thieme 2007: 107-141 Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials.. J Affect Disord 2005; 88 (3): 241-254 Werneke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction.. Acta Psychiatr Scand 2006; 114 (6): 384-397
